Clinical trial · Interventional
The Effect of Sujok Therapy on Cancer Symptoms
The Effect of Sujok Therapy on Pain, Fatigue, Insomnia, Nausea and Vomiting Experienced by Patients With Gastrointestinal System Cancer
NCT05265754CI-TRIAL-00064230completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to determine the effect of Sujok therapy on Pain, Fatigue, Insomnia, Nausea and Vomiting experienced by patients with gastrointestinal system cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| sujok therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Experimental group
- description
- In the hand area, firstly, the points will be determined by means of the diagnostic stick and massage will be applied with buckwheat seeds. This massage will be 3 sessions a week, and a total of 6 sessions in 2 weeks.
- interventionNames
- Behavioral: sujok therapy
- type
- NO_INTERVENTION
- label
- control group
- description
- A questionnaire will be applied to the patients by the researcher. Questionnaires will be made as pre-test and post-test.
Primary outcomes (4)
- measure
- Sujok Therapy's Positive Change in Pain Experienced by Gastrointestinal System Cancer Patients
- timeFrame
- 2 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * over 18 years old * Fatigue Severity Measurement - Visual Analogue Scale (VAS) fatigue score of 3 and above, * Pain Severity Measurement - Visual Analogue Scale (VAS) pain score of 3 and above, * Measurement of Nausea and Vomiting Severity - Patients with a Visual Analogue Scale (VAS) nausea and vomiting score of 3 and above will be included. Exclusion Criteria: * Loss of sensation, amputation, injury, colostomy, etc., which will prevent practice in hands. patients will be excluded from the study.
References
Publications (0)
Data not yet available
No reference posted for this study.